These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 29084642)

  • 1. Pirfenidone-induced phototoxic reaction in a patient with idiopathic pulmonary fibrosis.
    Woo YJ; Sohn KM; Kang H; Kim JE
    Eur J Dermatol; 2017 Oct; 27(5):545-546. PubMed ID: 29084642
    [No Abstract]   [Full Text] [Related]  

  • 2. Photobiological study in pirfenidone-induced photosensitivity.
    Muñoz-Aceituno E; Reolid A; Rodríguez-Jiménez P; Chicharro P; de Argila D
    Photodermatol Photoimmunol Photomed; 2020 Nov; 36(6):481-483. PubMed ID: 32516459
    [No Abstract]   [Full Text] [Related]  

  • 3. Pirfenidone photosensitization in patients with idiopathic pulmonary fibrosis: a case series.
    Droitcourt C; Adamski H; Polat A; Polard E; Kerjouan M; Arnouat B; Le Garrec M; Oger E; Dupuy A; Jouneau S
    Br J Dermatol; 2018 Mar; 178(3):e222-e223. PubMed ID: 28963722
    [No Abstract]   [Full Text] [Related]  

  • 4. Pirfenidone-induced photoleukomelanoderma in a patient with idiopathic pulmonary fibrosis.
    Tsuruta A; Washio K; Fukunaga A; Nishigori C
    J Dermatol; 2016 Feb; 43(2):207-9. PubMed ID: 26119131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pirfenidone induced phototoxic reaction in an elderly man.
    Gaikwad RP; Mukherjee SS
    Indian J Dermatol Venereol Leprol; 2016; 82(1):101-3. PubMed ID: 26728829
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pirfenidone (Esbriet
    Schmutz JL
    Ann Dermatol Venereol; 2018 Dec; 145(12):811-812. PubMed ID: 30348540
    [No Abstract]   [Full Text] [Related]  

  • 7. Severe Colitis Associated with Pirfenidone Use in Idiopathic Pulmonary Fibrosis.
    Fiddler CA; Simler N; Parfrey H; Miremadi A; Chilvers ER
    Ann Am Thorac Soc; 2016 Aug; 13(8):1430-2. PubMed ID: 27509160
    [No Abstract]   [Full Text] [Related]  

  • 8. Pirfenidone-Induced Sarcoid-Like Reaction: A Novel Complication.
    Kolaitis NA; Kukreja J; Jones KD; Hays SR; Leard LE
    Chest; 2018 Oct; 154(4):e89-e92. PubMed ID: 30290953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pirfenidone-induced phototoxic reaction.
    Morgado-Carrasco D; Massana J; Piquero-Casals J
    Int J Dermatol; 2021 May; 60(5):e202-e203. PubMed ID: 33615459
    [No Abstract]   [Full Text] [Related]  

  • 10. Perils with Pirfenidone and "the tuberculosis link".
    Hande MH; Acharya KV; Shreenivasa A; Nayak K; Arun S
    Int J Mycobacteriol; 2019; 8(3):298-301. PubMed ID: 31512609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective analysis of skin photosensitivity induced by pirfenidone.
    Wang C; He Y; Sun W; Wu C; Li Z; Sun L
    J Clin Pharm Ther; 2022 Feb; 47(2):194-199. PubMed ID: 34655088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A rare case of drug-induced hypersensitivity syndrome by pirfenidone for idiopathic pulmonary fibrosis.
    Suda K; Kamiya K; Chiang B; Okada H; Mato N; Maekawa T; Komine M; Murata S; Ohtsuki M
    Allergol Int; 2018 Jul; 67(3):425-426. PubMed ID: 29588165
    [No Abstract]   [Full Text] [Related]  

  • 13. Intraindividual response to treatment with pirfenidone in idiopathic pulmonary fibrosis.
    Loeh B; Drakopanagiotakis F; Bandelli GP; von der Beck D; Tello S; Cordani E; Rizza E; Barrocu L; Markart P; Seeger W; Guenther A; Albera C
    Am J Respir Crit Care Med; 2015 Jan; 191(1):110-3. PubMed ID: 25551350
    [No Abstract]   [Full Text] [Related]  

  • 14. Positive photopatch test to pirfenidone.
    Forbat E; Parr D; Shim TN
    Contact Dermatitis; 2021 May; 84(5):341-342. PubMed ID: 33184898
    [No Abstract]   [Full Text] [Related]  

  • 15. Eosinophilic pneumonia associated with pirfenidone therapy.
    Gomez DC; Mehrad B
    Eur Respir J; 2016 Oct; 48(4):1240-1242. PubMed ID: 27390279
    [No Abstract]   [Full Text] [Related]  

  • 16. Pirfenidone in idiopathic pulmonary fibrosis.
    Swigris J; Fairclough D
    Eur Respir J; 2010 Sep; 36(3):695-6; author reply 696-8. PubMed ID: 20930209
    [No Abstract]   [Full Text] [Related]  

  • 17. Pirfenidone in respirable powder form for the treatment of pulmonary fibrosis: a safer alternative to the current oral delivery system?
    Onoue S; Yamada S
    Ther Deliv; 2013 Aug; 4(8):887-9. PubMed ID: 23919466
    [No Abstract]   [Full Text] [Related]  

  • 18. Pirfenidone-Related Blue-Gray Pigmentation of the Skin.
    Syscos SM; Duncan JR; Stratton MS; Pavlidakey PG; Graham L
    Skinmed; 2018; 16(5):358-360. PubMed ID: 30413237
    [No Abstract]   [Full Text] [Related]  

  • 19. Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials.
    Noble PW; Albera C; Bradford WZ; Costabel U; Glassberg MK; Kardatzke D; King TE; Lancaster L; Sahn SA; Szwarcberg J; Valeyre D; du Bois RM;
    Lancet; 2011 May; 377(9779):1760-9. PubMed ID: 21571362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Open-Label Study of the Long-Term Safety of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis (RECAP).
    Costabel U; Albera C; Lancaster LH; Lin CY; Hormel P; Hulter HN; Noble PW
    Respiration; 2017; 94(5):408-415. PubMed ID: 28898890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.